PRECISE BIOMETRICS AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.476 SEK | -2.38% |
|
-6.58% | +34.18% |
| Apr. 05 | Precise Biometrics, Flowscape Expand Sales Distribution Deal | MT |
| Apr. 05 | Precise Biometrics Signs New Customer and Deepens Partnership with Flowscape Technology | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 610.2 | 443.8 | 546.4 | 188 | 85.12 | 114.2 | - | - |
| Enterprise Value (EV) 1 | 536.6 | 367.5 | 595.3 | 206.6 | 90.93 | 97.21 | 99.21 | 88.21 |
| P/E ratio | - | -41.1 x | -34.5 x | -8.44 x | -3.24 x | -7.38 x | -14.8 x | 14.8 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 6.64 x | 4.81 x | 6.56 x | 2.07 x | 1.13 x | 1.27 x | 1.08 x | 0.94 x |
| EV / Revenue | 5.84 x | 3.98 x | 7.15 x | 2.27 x | 1.21 x | 1.08 x | 0.94 x | 0.72 x |
| EV / EBITDA | 38.9 x | 53.6 x | 318 x | 180 x | -53.8 x | 97.2 x | 6.61 x | 2.85 x |
| EV / FCF | -30.1 x | 91.9 x | -18.7 x | -3.68 x | -2.52 x | -7.48 x | -49.6 x | 8.02 x |
| FCF Yield | -3.32% | 1.09% | -5.33% | -27.1% | -39.7% | -13.4% | -2.02% | 12.5% |
| Price to Book | 4.84 x | 3.85 x | 4.31 x | 1.31 x | 0.54 x | - | - | - |
| Nbr of stocks (in thousands) | 36,023 | 36,023 | 39,596 | 46,428 | 77,379 | 77,379 | - | - |
| Reference price 2 | 16.94 | 12.32 | 13.80 | 4.050 | 1.100 | 1.476 | 1.476 | 1.476 |
| Announcement Date | 2/14/20 | 2/16/21 | 2/18/22 | 2/17/23 | 2/16/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 91.93 | 92.35 | 83.32 | 91.02 | 75.07 | 90 | 106 | 122 |
| EBITDA 1 | 13.79 | 6.862 | 1.872 | 1.147 | -1.691 | 1 | 15 | 31 |
| EBIT 1 | 0.651 | -5.792 | -14.07 | -20.02 | -26.46 | -18 | -6 | 6 |
| Operating Margin | 0.71% | -6.27% | -16.89% | -21.99% | -35.24% | -20% | -5.66% | 4.92% |
| Earnings before Tax (EBT) 1 | 0.095 | -6.41 | -13.35 | -23.47 | -26.75 | -19 | -7 | 5 |
| Net income 1 | 0.594 | -12.24 | -13.45 | -22.23 | -26.4 | -19 | -7 | 5 |
| Net margin | 0.65% | -13.25% | -16.14% | -24.42% | -35.17% | -21.11% | -6.6% | 4.1% |
| EPS 2 | - | -0.3000 | -0.4000 | -0.4800 | -0.3400 | -0.2000 | -0.1000 | 0.1000 |
| Free Cash Flow 1 | -17.81 | 3.999 | -31.75 | -56.08 | -36.08 | -13 | -2 | 11 |
| FCF margin | -19.37% | 4.33% | -38.11% | -61.61% | -48.06% | -14.44% | -1.89% | 9.02% |
| FCF Conversion (EBITDA) | - | 58.28% | - | - | - | - | - | 35.48% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | 220% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/14/20 | 2/16/21 | 2/18/22 | 2/17/23 | 2/16/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 16.9 | 27.43 | 28.31 | 24.61 | 18.82 | 19.28 | 19.15 | 17.89 | 17.72 | 20.31 |
| EBITDA 1 | 0.998 | 1.666 | 4.02 | 0.942 | -1.829 | -1.986 | -0.625 | -0.569 | -1.088 | 0.59 |
| EBIT 1 | -2.972 | -2.693 | -0.802 | -4.109 | -7.341 | -7.764 | -6.862 | -6.895 | -7.28 | -5.421 |
| Operating Margin | -17.58% | -9.82% | -2.83% | -16.69% | -39.01% | -40.28% | -35.83% | -38.55% | -41.08% | -26.69% |
| Earnings before Tax (EBT) 1 | -2.911 | -2.34 | -1.248 | -4.394 | -7.535 | -10.29 | -7.028 | -6.887 | -7.786 | -5.048 |
| Net income 1 | -2.913 | -2.432 | -1.162 | -4.307 | -7.447 | -9.314 | -6.941 | -6.804 | -7.697 | -4.961 |
| Net margin | -17.23% | -8.86% | -4.1% | -17.5% | -39.58% | -48.32% | -36.25% | -38.04% | -43.43% | -24.43% |
| EPS 2 | -0.1000 | -0.1000 | - | -0.1100 | -0.1900 | -0.2000 | -0.1500 | -0.0900 | -0.1000 | -0.0600 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/12/21 | 2/18/22 | 5/13/22 | 8/12/22 | 11/11/22 | 2/17/23 | 5/9/23 | 8/15/23 | 11/10/23 | 2/16/24 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 48.9 | 18.6 | 5.81 | - | - | - |
| Net Cash position 1 | 73.7 | 76.3 | - | - | - | 17 | 15 | 26 |
| Leverage (Debt/EBITDA) | - | - | 26.12 x | 16.22 x | -3.437 x | - | - | - |
| Free Cash Flow 1 | -17.8 | 4 | -31.8 | -56.1 | -36.1 | -13 | -2 | 11 |
| ROE (net income / shareholders' equity) | 0.5% | -10.2% | -11.1% | -16.2% | -16.3% | -13% | -5% | 4% |
| ROA (Net income/ Total Assets) | 0.37% | - | - | - | - | - | - | - |
| Assets 1 | 158.6 | - | - | - | - | - | - | - |
| Book Value Per Share | 3.500 | 3.200 | 3.200 | 3.080 | 2.030 | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 5.84 | 17.8 | 30.3 | 60 | 25.3 | 3 | 3 | 4 |
| Capex / Sales | 6.36% | 19.27% | 36.32% | 65.93% | 33.72% | 3.33% | 2.83% | 3.28% |
| Announcement Date | 2/14/20 | 2/16/21 | 2/18/22 | 2/17/23 | 2/16/24 | - | - | - |
1SEK in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +34.18% | 10.4M | |
| -23.60% | 1.59B | |
| +168.41% | 151M | |
| +16.07% | 121M | |
| -31.21% | 48.04M |
- Stock Market
- Equities
- PREC Stock
- Financials Precise Biometrics AB
